Tuesday, December 5, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Derivative

CHICAGO - Shareholders claim Abbott Laboratories execs profited handsomely while hurting shareholders through illegal off-label marketing of Depakote, which cost the company a $1.3 billion settlement with the USA and 24 states.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.